CHRYSALIS BIOTHERAPEUTICS
LIVE

Serial Number

90052179

Owner

Chrysalis BioTherapeutics, Inc.

Attorney

Shannon T. Vale

Filing Date

Jul 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CHRYSALIS BIOTHERAPEUTICS Trademark

Serial Number: 90052179

CHRYSALIS BIOTHERAPEUTICS is a trademark filed by Chrysalis BioTherapeutics, Inc. on July 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Chrysalis BioTherapeutics, Inc. (2 trademarks)

Galveston, TX 77550

Entity Type: 03

Trademark Details

Filing Date

July 14, 2020

Registration Date

Not Registered

Published for Opposition

March 16, 2021

Goods & Services

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jan 3, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 2, 2025 AITU
USE AMENDMENT FILED
May 13, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 13, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2023 EXRA
SOU EXTENSION 5 GRANTED
Nov 17, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 17, 2023 AITU
SOU EXTENSION 5 FILED
Nov 10, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 8, 2023 EX4G
SOU EXTENSION 4 FILED
May 8, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 8, 2023 EEXT
ASSIGNED TO EXAMINER
Nov 14, 2022 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 8, 2022 EXRA
SOU EXTENSION 3 GRANTED
Nov 4, 2022 EX3G
SOU EXTENSION 3 FILED
Nov 4, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 9, 2022 EX2G
SOU EXTENSION 2 FILED
May 9, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 9, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 7, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 7, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 7, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 11, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 11, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 11, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 11, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 8, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 8, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 8, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 8, 2021 CNEA
ASSIGNED TO EXAMINER
Feb 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2020 NWOS
NEW APPLICATION ENTERED
Jul 17, 2020 NWAP